NCT07421609

Brief Summary

This study evaluates whether strain counterstrain therapy affects pain, fatigue, psychological status, and quality of life in women diagnosed with fibromyalgia. Participants are assigned to one of three groups: a control group, a conservative treatment group, or a conservative treatment plus strain counterstrain therapy group. Treatment sessions are conducted five days per week for three weeks. Outcomes are assessed before and after the intervention using validated measurement scales. The purpose is to compare changes among groups and determine the effects of adding strain counterstrain therapy to conservative treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2025

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 19, 2026

Completed
Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

February 12, 2026

Last Update Submit

February 23, 2026

Conditions

Keywords

Fibromyalgia SyndromePain

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Intensity (Visual Analog Scale)

    Pain intensity is assessed using the Visual Analog Scale (VAS), a validated measure consisting of a 10-cm line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants indicate their pain level on the scale, and change is calculated as the difference between pre-intervention and post-intervention scores.

    Baseline and immediately after completion of the 3-week intervention period

Secondary Outcomes (4)

  • Change in Fatigue Severity Score (Fatigue Severity Scale)

    Baseline and immediately after completion of the 3-week intervention period

  • Change in Depression Score (Beck Depression Inventory)

    Baseline and immediately after completion of the 3-week intervention period

  • Change in Anxiety Score (Beck Anxiety Inventory)

    Baseline and immediately after completion of the 3-week intervention period

  • Change in Fibromyalgia Impact Score (Fibromyalgia Impact Questionnaire)

    Baseline and immediately after completion of the 3-week intervention period

Study Arms (3)

Control Group

NO INTERVENTION

Participants in this group do not receive any therapeutic intervention during the study period and continue their usual daily activities. Outcome assessments are performed at baseline and after the study period for comparison with the intervention groups.

Conservative Treatment Group

ACTIVE COMPARATOR

Participants in this group receive conservative treatment consisting of standard physiotherapy modalities administered five days per week for three weeks according to a structured treatment protocol. No strain counterstrain therapy is applied in this group.

Other: Conservative Physiotherapy Program

Conservative Treatment Plus Strain Counterstrain Group

EXPERIMENTAL

Participants in this group receive conservative treatment consisting of standard physiotherapy modalities administered five days per week for three weeks, together with strain counterstrain therapy applied according to a structured manual therapy protocol.

Procedure: Strain Counterstrain Therapy

Interventions

The conservative physiotherapy program consists of standard physical therapy modalities applied according to a structured treatment protocol. Sessions are conducted five days per week for three weeks and include routinely used physiotherapy approaches intended to support symptom management and functional improvement.

Conservative Treatment Group

Strain counterstrain therapy is a manual therapy technique applied by a trained therapist using passive positioning methods intended to reduce musculoskeletal tenderness and improve comfort. The intervention is administered according to a structured treatment protocol during scheduled sessions over the study period.

Conservative Treatment Plus Strain Counterstrain Group

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly individuals who identify as female are eligible to participate.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Female participants aged within the predefined study age range
  • Diagnosis of fibromyalgia according to established clinical criteria
  • Ability to participate in treatment sessions and assessments
  • Willingness to participate and provide informed consent

You may not qualify if:

  • Those in menopause or postmenstrual period,
  • Those with psychiatric, neurological and/or chronic progressive systemic disease,
  • Those with immunodeficiency,
  • Those with heart, kidney, or liver failure,
  • Those receiving any pharmacological treatment,
  • Those with health issues preventing participation in the treatment programmes,
  • Pregnant patients were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University Turgut Ozal Medical Center

Malatya, 4400, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FibromyalgiaPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ilker DEMİR, PhD

    Inonu University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of three parallel groups: a control group, a conservative treatment group, or a conservative treatment plus strain counterstrain therapy group. All groups are followed over the same study period, and outcomes are assessed before and after the intervention to compare changes among groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 12, 2026

First Posted

February 19, 2026

Study Start

October 4, 2024

Primary Completion

November 12, 2025

Study Completion

December 1, 2025

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations